| RCC | renal cell carcinoma |
| mRCC | metastatic RCC |
| ICIs | immune checkpoint inhibitors |
| PD1 | programmed death receptor 1 |
| PD-L1 | PD-ligand 1 |
| NSCLC | non-small cell lung cancer |
| WHO | World Health Organization |
| PR | partial response |
| CR | complete response |
| PD | disease progression |
| SPD | sum of products of the two largest perpendicular diameters |
| irRC | immune-related response criteria |
| SD | stable disease |
| RECIST | response evaluation criteria in solid tumors |
| irRECIST | immune-related RECIST |
| imRECIST | immune-modified RECIST |
| iRECIST | immune RECIST |
| iUPD | unconfirmed PD |
| iCPD | confirmed PD |
| TBP | treatment beyond progression |
| PFS | progression-free survival |
| OS | overall survival |
| ORR | overall response rate |
| CAR | chimeric antigen receptor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.